Association of status of acetylcholinesterase and ACHE gene 3' UTR variants (rs17228602, rs17228616) with drug addiction vulnerability in pakistani population
- PMID: 31129131
- DOI: 10.1016/j.cbi.2019.05.036
Association of status of acetylcholinesterase and ACHE gene 3' UTR variants (rs17228602, rs17228616) with drug addiction vulnerability in pakistani population
Abstract
Substance addiction is a chronic, relapsing mental disorder Characterized by compulsive drug seeking, and loss of control over drug intake and relapse after prolonged abstinence. Genetics has been shown to contribute towards an individual's vulnerability to addiction. Acetylecholine (ACh), a cholinergic neurotransmitter hydrolyzed by acetylcholinesterase (AChE), is an essential neurotransmitter and neuromodulator in central and peripheral nervous system and has regulatory influence on numerous neuronal functions including addiction. The present study was carried out to investigate the role of acetylcholinesterase (AChE) in addiction through measurement of enzyme activity and to find potential association of ACHE gene 3'UTR variants rs17228602 and rs17228616 in heroin, hashish and poly drug addicts. Both SNPs are located within microRNA (miRNA) recognition sites with potential to affect miRNA/transcript interaction. A total of 122 addicts of heroin, hashish and polydrug were recruited from local rehabilitation centers to participate in this study. AChE activity was measured in blood by Ellman's method. SNP genotyping was performed by restriction fragment length polymorphism (PCR-RFLP) and Sanger sequencing. The AChE activity was found significantly higher (p ≤ 0.005) in addicted cohort (mean ± standard error of mean 0.020 ± 0.001 μmol/L/min; 95% confidence interval (CI) 0.018-0.022) in comparison to non-addicted healthy subjects (0.011 ± 0.001 μmol/L/min; 95% confidence interval CI 0.010-0.013). A statistically significant association of ACHE rs17228602 SNP with addiction vulnerability in dominant (DM: Odd's ratio OR = 2.095, 95% CI = 1.157-3.807 p = 0.009) and allelic genetic models (OR = 1.854 95% CI = 1.082-3.187, p = 0.016) was observed. However, no statistically significant association of rs17228616 SNP with substance abuse disorder was found. The data presented here shows that AChE could play significant role in substance addiction. Further studies with larger sample size and other variants of AChE are recommended to identify novel therapeutic approaches for cholinergic based treatment of addiction.
Keywords: 3′UTR variants; ACHE; Acetylcholinesterase; Addiction; Heroin; SNP.
Copyright © 2019 Elsevier B.V. All rights reserved.
Similar articles
-
Cannabis Constituents and Acetylcholinesterase Interaction: Molecular Docking, In Vitro Studies and Association with CNR1 rs806368 and ACHE rs17228602.Biomolecules. 2020 May 13;10(5):758. doi: 10.3390/biom10050758. Biomolecules. 2020. PMID: 32414087 Free PMC article.
-
Biochemical Analysis and Association of Butyrylcholinesterase SNPs rs3495 and rs1803274 with Substance Abuse Disorder.J Mol Neurosci. 2019 Mar;67(3):445-455. doi: 10.1007/s12031-018-1251-7. Epub 2019 Feb 1. J Mol Neurosci. 2019. PMID: 30707402
-
Epistatic effects between variants of kappa-opioid receptor gene and A118G of mu-opioid receptor gene increase susceptibility to addiction in Indian population.Prog Neuropsychopharmacol Biol Psychiatry. 2012 Mar 30;36(2):225-30. doi: 10.1016/j.pnpbp.2011.10.018. Epub 2011 Nov 28. Prog Neuropsychopharmacol Biol Psychiatry. 2012. PMID: 22138325
-
Personalized genetics of the cholinergic blockade of neuroinflammation.J Neurochem. 2017 Aug;142 Suppl 2(Suppl Suppl 2):178-187. doi: 10.1111/jnc.13928. Epub 2017 Mar 21. J Neurochem. 2017. PMID: 28326544 Free PMC article. Review.
-
BDNF rs6265 polymorphism and drug addiction: a systematic review and meta-analysis.Pharmacogenomics. 2013 Dec;14(16):2055-65. doi: 10.2217/pgs.13.217. Pharmacogenomics. 2013. PMID: 24279859
Cited by
-
Acetylcholinesterase, pro-inflammatory cytokines, and association of ACHE SNP rs 17228602 with male infertility.PLoS One. 2023 Apr 7;18(4):e0282579. doi: 10.1371/journal.pone.0282579. eCollection 2023. PLoS One. 2023. PMID: 37027384 Free PMC article.
-
Enzyme ChE, cholinergic therapy and molecular docking: Significant considerations and future perspectives.Int J Immunopathol Pharmacol. 2024 Jan-Dec;38:3946320241289013. doi: 10.1177/03946320241289013. Int J Immunopathol Pharmacol. 2024. PMID: 39367568 Free PMC article. Review.
-
Cannabis Constituents and Acetylcholinesterase Interaction: Molecular Docking, In Vitro Studies and Association with CNR1 rs806368 and ACHE rs17228602.Biomolecules. 2020 May 13;10(5):758. doi: 10.3390/biom10050758. Biomolecules. 2020. PMID: 32414087 Free PMC article.
-
Synthesis, Characterization, and Biological Effects of Chloro-Cathinones: Toxicity and Potential Neurological Impact.Int J Mol Sci. 2025 Apr 9;26(8):3540. doi: 10.3390/ijms26083540. Int J Mol Sci. 2025. PMID: 40332042 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical